HOPE-Kenya: Preventing cervical cancer for women with HIV in Nairobi
HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya)
This project offers integrated cervical cancer screening and follow-up care to women living with HIV at a Nairobi clinic to close gaps in prevention and treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11103238 on NIH RePORTER |
What this research studies
At the Coptic Hope Center in Nairobi you would be offered cervical cancer screening as part of your HIV care, using HPV testing and clinical exams. If screening finds anything concerning, the team will arrange timely follow-up such as biopsies, treatment, or referral so you are not lost in the care process. The site is building clinical research capacity to try different ways of improving screening uptake, linking positive results to treatment, and keeping patients in care. The project may also collect routine blood or tissue samples and track outcomes over time to improve services for women like you.
Who could benefit from this research
Good fit: Women living with HIV who receive care at or can travel to participating clinics in Nairobi—particularly patients of the Coptic Hope Center—are the ideal candidates.
Not a fit: People who are not women living with HIV, those outside the clinic's geographic area, or individuals with advanced cancer needing specialized tertiary care may not receive direct benefit from this project.
Why it matters
Potential benefit: If successful, this work could lead to earlier detection and faster treatment of cervical precancer in women with HIV, reducing cancers and deaths.
How similar studies have performed: Similar integrated screening and treatment programs in sub-Saharan Africa have improved detection and treatment linkage, though expanding and testing interventions at this scale remains an important next step.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Chung, Michael Hoonbae — Emory University
- Study coordinator: Chung, Michael Hoonbae
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.